Submit Deal

AKTIS ONCOLOGY

HQ - Boston, Massachusetts

Summary

Aktis Oncology, a biotechnology company discovering and developing novel targeted radiopharmaceuticals to treat a broad range of solid tumors.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 131 M

Avg. Deal Size£ 131 M

Market Context

Senior Management

Sort

matthew roden

President and CEO at AKTIS ONCOLOGY

Manager

Deals

£ 131 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy